IRadimed Corporation
IRMD
$96.55
$0.290.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.17% | 10.44% | 17.81% | 13.32% | 13.37% |
| Total Depreciation and Amortization | 95.03% | 94.18% | 4.22% | -14.15% | -4.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 606.28% | 8.02% | 134.36% | -3.92% | -16.21% |
| Change in Net Operating Assets | -1,952.46% | -92.87% | -40.29% | -2.44% | 115.81% |
| Cash from Operations | -1.07% | -23.36% | 16.69% | 10.53% | 53.01% |
| Capital Expenditure | 89.46% | 70.14% | -132.36% | -1,266.41% | -424.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 54.20% | 37.52% | -38.75% | -5.57% | -164.42% |
| Cash from Investing | 86.38% | 68.50% | -122.37% | -718.15% | -383.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -84.83% |
| Repurchase of Common Stock | -327.66% | -66.29% | -50.23% | -82.00% | -25.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -350.01% | -13.79% | -13.79% | 72.90% | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -349.78% | -14.28% | -15.17% | 71.67% | -820.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,146.03% | 10.81% | -21.82% | 58.95% | -82.99% |